about
Antiangiogenic activity of sterically stabilized liposomes containing paclitaxel (SSL-PTX): in vitro and in vivo.Metastatic primary duodenal adeno-carcinoma responding to metronomic oral cyclophosphamide chemotherapyMethyl 2-cyano-3,11-dioxo-18-olean-1,12-dien-30-oate (CDODA-Me), a derivative of glycyrrhetinic acid, functions as a potent angiogenesis inhibitor.Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature.Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs.Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1.Tumoral angiogenesis: review of the literature.Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.Metronomic Capecitabine Effectively Blocks Leptomeningeal Carcinomatosis From Breast Cancer: A Case Report and Literature Review.Metronomics: towards personalized chemotherapy?Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer.Repeated tumor oximetry to identify therapeutic window during metronomic cyclophosphamide treatment of 9L gliomas.Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells.CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study.Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer.Hepatic colorectal cancer metastases showing a distinctive pattern of pathological response after metronomic capecitabine and bevacizumab.
P2860
Q33985966-DAD89602-C8F8-477B-8CBC-245A4214A4D1Q34131391-E88E8AB0-5B7C-4AE1-9A11-433A775A0FC4Q34214684-DB0DA741-CB79-426E-A906-40B7C3C01ECEQ34414279-F8D00C5B-8491-4283-8252-ADFA178E4024Q34747015-86C03A23-C5BC-4D9C-9B48-F517AF9EC1A1Q36209145-39C1975D-6172-48D6-9B77-339BBE18C070Q36282739-A627EEAD-850F-4BEF-9224-C0E99D3EA9DAQ37052761-38B19B81-E09E-41C4-AF87-A214B60C306AQ37528441-AAED0F2A-46E3-4CE5-94A7-69BC420E1FC8Q37684584-84123189-F8DE-4039-9845-1135A8950992Q38218923-01BC2633-69DE-4FD1-BAEB-B9D98B09DF58Q39340865-3011CFD0-52FF-4718-9053-8836D78762B5Q39556514-BD339035-E971-47A5-8B52-FE48DC72468EQ44084942-8AB20262-EB4F-418F-98CB-01C4009AC7B3Q46085386-91BD2822-9310-4759-B076-BF665C506D2BQ47149222-D48AD7CB-7205-460F-80D7-392B7D86DE76Q53178962-D9BEAA80-0C19-483F-836C-8ACA09AB3FCA
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Metronomic chemotherapy: an antiangiogenic scheduling.
@en
type
label
Metronomic chemotherapy: an antiangiogenic scheduling.
@en
prefLabel
Metronomic chemotherapy: an antiangiogenic scheduling.
@en
P2093
P1476
Metronomic chemotherapy: an antiangiogenic scheduling.
@en
P2093
P2888
P356
10.1007/S12094-007-0018-3
P577
2007-02-01T00:00:00Z